Zevra Therapeutics Presents Design of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH) at Beyond Sleepy 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming poster presentation highlighting the Company's IRAK1/4 program at the...
Netherlands-based Caelus Health has received a letter of no objection from the US FDA regarding the GRAS (generally recognized as safe) status for a next-generation microbe.
Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint research project to discover disease specific... | May 10, 2023
The FDA approved Arexvy, the world's first vaccine for respiratory syncytial virus (RSV), on Wednesday. Manufactured by GlaxoSmithKline Pharmaceuticals, the RSV vaccine is approved for use in people ages 60 and older.
Netherlands-based Caelus Health has received a letter of no objection from the US FDA regarding the GRAS (generally recognized as safe) status for a next-generation microbe.
Netherlands-based Caelus Health has received a letter of no objection from the US FDA regarding the GRAS (generally recognized as safe) status for a next-generation microbe.